Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03108001 · ClinicalTrials.gov registry record
Glowing and Expecting Follow Up
A clinical trial of Healthy, sponsored by Arkansas Children's Hospital Research Institute.
- Recruiting
- Registry status
- 514
- Enrollment target
- 1
- Study location
NCT03108001: Recruiting study of Healthy, sponsored by Arkansas Children's Hospital Research Institute.
NCT03108001 is a study of Healthy that is actively recruiting participants, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 514 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03108001, a study of Healthy, is actively recruiting participants, sponsored by Arkansas Children's Hospital Research Institute.
- RECRUITING
- Registry status
- 514 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will help us learn more about how a mother's health during pregnancy may influence her child's growth and development later in life.
Primary Outcome
Will be determined with body composition equipment (DXA and NMR)
Conditions Studied
Study Locations (1)
Arkansas
- Arkansas Children's Nutrition Center - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 514 participants |
| Start Date | 2017-03-27 |
| Est. Completion | 2031-03-01 |
What NCT03108001 shows while recruiting
NCT03108001 is an observational study that tracks outcomes without assigning an intervention. The registered 514 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (21% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT03108001 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT03108001 about?
NCT03108001 is a clinical study titled "Glowing and Expecting Follow Up". This study will help us learn more about how a mother's health during pregnancy may influence her child's growth and development later in life.
What is the current status of trial NCT03108001?
This trial is currently recruiting. The enrollment target is 514 participants. The study started on 2017-03-27. Estimated completion is 2031-03-01.
What conditions does trial NCT03108001 study?
This clinical trial studies the following conditions: Healthy.
Who is sponsoring clinical trial NCT03108001?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03108001 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03108001's enrollment target sits among peer trials
514 47th of 1090 higher than 1,044 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- NCT06585488 · 514 participants · Phase 1
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
- NCT06716606 · 514 participants · Phase 3
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI